Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations

Published:2017-07-11 Issue:3 Volume:59 Page:739-742
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Damlaj Moussab¹²³,Al Balwi Mohammed²³⁴,Al Mugairi Areej M.⁴

Affiliation:

1. Division of Hematology & HSCT, Department of Oncology, King Abdul-Aziz Medical City, Riyadh, KSA;

2. King Abdullah International Medical Research Center, Riyadh, KSA;

3. King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA;

4. Department of Pathology and Laboratory Medicine, King Abdul-Aziz Medical City, Riyadh, KSA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1347653

Reference14 articles.

1. Chronic Lymphoid Leukemias Other Than Chronic Lymphocytic Leukemia: Diagnosis and Treatment

2. Aberrations of MYC Are a Common Event in B-Cell Prolymphocytic Leukemia

3. p53 Abnormalities in B-Cell Prolymphocytic Leukemia

4. Cytogenetic Abnormalities in Three Patients with B-Cell Prolymphocytic Leukemia

5. Alemtuzumab in Relapsed or Refractory Chronic Lymphocytic Leukemia and Prolymphocytic Leukemia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolymphocytic Leukaemia: an Update on Biology and Treatment;Current Oncology Reports;2024-01-02

2. An effective treatment and suspicious adverse reaction to Ibrutinib in a patient diagnosed with splenic B-cell lymphoma/leukaemia with prominent nucleoli: A first case report;Medicine;2023-12-29

3. De-Novo B-Cell Prolymphocytic Leukemia;Journal of Hematology;2023-04

4. Retrospective analysis of a cohort of 41 <i>de novo</i> B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study);Haematologica;2022-12-22

5. Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53 mutated B-cell prolymphocytic leukemia: a case report and review of literature;Haematologica;2021-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3